Today's Top Stories | | By Sam Quirke | March 11, 2025 09:05 AM |
| | | By The Associated Press | March 11, 2025 09:00 AM |
| | By Chris Markoch | March 11, 2025 07:15 AM |
| | | By The Associated Press | March 11, 2025 08:57 AM |
| | By Gabriel Osorio-Mazilli | March 10, 2025 09:30 AM |
|
|
Analysts' Upgrades | BankUnited (NYSE:BKU) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $41.00 price target on the stock. This represents a 27.3% upside from the current price of $32.21. | CenterPoint Energy (NYSE:CNP) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $37.00 price target on the stock, up previously from $36.00. This represents a 6.5% upside from the current price of $34.74. | Capital One Financial (NYSE:COF) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $200.00 price target on the stock, up previously from $190.00. This represents a 20.6% upside from the current price of $165.86. | FB Financial (NYSE:FBK) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $58.00 price target on the stock. This represents a 27.9% upside from the current price of $45.34. | First Citizens BancShares (NASDAQ:FCNCA) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $2,250.00 price target on the stock. This represents a 29.2% upside from the current price of $1,741.48. | GE HealthCare Technologies (NASDAQ:GEHC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $100.00 price target on the stock, up previously from $85.00. This represents a 12.7% upside from the current price of $88.76. | Genmab A/S (NASDAQ:GMAB) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $20.27. | Houlihan Lokey (NYSE:HLI) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "overweight" rating. They now have a $179.00 price target on the stock, down previously from $180.00. This represents a 13.4% upside from the current price of $157.84. | Lumentum (NASDAQ:LITE) was upgraded by analysts at BNP Paribas from a "neutral" rating to an "outperform" rating. They now have a $92.00 price target on the stock. This represents a 48.1% upside from the current price of $62.13. | MSG Entertainment (NYSE:MSGE) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $46.00 price target on the stock. This represents a 41.4% upside from the current price of $32.53. | NET Power (NYSE:NPWR) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $6.00 price target on the stock, down previously from $14.00. This represents a 103.0% upside from the current price of $2.96. | ON (NYSE:ONON) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $58.00 price target on the stock. This represents a 27.0% upside from the current price of $45.68. | PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "neutral" rating. They now have a $55.00 price target on the stock, up previously from $41.00. This represents a 7.3% upside from the current price of $51.24. | TXNM Energy (NYSE:TXNM) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $53.00 price target on the stock. This represents a 2.9% upside from the current price of $51.51. | Unity Software (NYSE:U) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $30.00 price target on the stock. This represents a 39.3% upside from the current price of $21.54. |
| View More Upgrades
|
Analysts' Downgrades | Afya (NASDAQ:AFYA) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $17.00 price target on the stock, down previously from $19.00. This represents a 8.4% upside from the current price of $15.68. | Franco-Nevada (NYSE:FNV) (TSE:FNV) was downgraded by analysts at TD Securities from a "buy" rating to a "hold" rating.The current price is $145.75. | Freshpet (NASDAQ:FRPT) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $83.01. | Green Plains (NASDAQ:GPRE) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $6.00 price target on the stock, down previously from $14.00. This represents a 20.1% upside from the current price of $5.00. | Lennar (NYSE:LEN) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating. They now have a $141.00 price target on the stock, down previously from $152.00. This represents a 14.0% upside from the current price of $123.65. | Lloyds Banking Group (NYSE:LYG) was downgraded by analysts at Keefe, Bruyette & Woods from an "outperform" rating to a "market perform" rating.The current price is $3.56. | Uber Technologies (NYSE:UBER) was downgraded by analysts at Fox Advisors from an "overweight" rating to an "equal weight" rating.The current price is $72.89. |
| View More Downgrades
|
Analysts' New Coverage | Backblaze (NASDAQ:BLZE) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $8.00 price target on the stock. This represents a 56.6% upside from the current price of $5.11. | Coeur Mining (NYSE:CDE) is now covered by analysts at TD Securities. They set a "buy" rating and a $7.00 price target on the stock. This represents a 29.5% upside from the current price of $5.41. | Gyre Therapeutics (NASDAQ:GYRE) is now covered by analysts at Noble Financial. They set an "outperform" rating on the stock.The current price is $11.50. | Hesai Group (NASDAQ:HSAI) is now covered by analysts at Daiwa Capital Markets. They set a "buy" rating and a $35.00 price target on the stock. This represents a 53.4% upside from the current price of $22.81. | Immunome (NASDAQ:IMNM) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $20.00 price target on the stock. This represents a 131.2% upside from the current price of $8.65. | Inuvo (NYSE:INUV) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $2.00 price target on the stock. This represents a 451.0% upside from the current price of $0.36. | Lakeland Industries (NASDAQ:LAKE) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $30.00 price target on the stock. This represents a 48.9% upside from the current price of $20.15. | El Pollo Loco (NASDAQ:LOCO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $18.00 price target on the stock. This represents a 67.9% upside from the current price of $10.72. | Molecular Partners (NASDAQ:MOLN) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $12.00 price target on the stock. This represents a 158.3% upside from the current price of $4.65. | Murphy USA (NYSE:MUSA) is now covered by analysts at Melius. They set a "buy" rating and a $600.00 price target on the stock. This represents a 28.7% upside from the current price of $466.16. | Northpointe Bancshares (NYSE:NPB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $16.50 price target on the stock. This represents a 20.0% upside from the current price of $13.75. | Northpointe Bancshares (NYSE:NPB) is now covered by analysts at Keefe, Bruyette & Woods. They set an "outperform" rating and a $18.00 price target on the stock. This represents a 30.9% upside from the current price of $13.75. | Ocular Therapeutix (NASDAQ:OCUL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $15.00 price target on the stock. This represents a 74.5% upside from the current price of $8.60. | Primoris Services (NASDAQ:PRIM) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $73.00 price target on the stock. This represents a 16.1% upside from the current price of $62.86. | Red Cat (NASDAQ:RCAT) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $13.00 price target on the stock. This represents a 172.1% upside from the current price of $4.78. | Sage Therapeutics (NASDAQ:SAGE) is now covered by analysts at Bank of America Co.. They set an "underperform" rating and a $5.00 price target on the stock. This represents a 30.0% downside from the current price of $7.14. | Spotify Technology (NYSE:SPOT) is now covered by analysts at Redburn Atlantic. They set a "neutral" rating and a $545.00 price target on the stock. This represents a 8.3% upside from the current price of $503.23. | Protara Therapeutics (NASDAQ:TARA) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 475.2% upside from the current price of $3.83. | Eco Wave Power Global AB (publ) (NASDAQ:WAVE) is now covered by analysts at Maxim Group. They set a "buy" rating and a $15.00 price target on the stock. This represents a 106.0% upside from the current price of $7.28. | Westwater Resources (NASDAQ:WWR) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $2.50 price target on the stock. This represents a 312.5% upside from the current price of $0.61. | Zymeworks (NYSE:ZYME) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $30.00 price target on the stock. This represents a 168.6% upside from the current price of $11.17. |
| View More New Coverage
|
Calendars from MarketBeat | |
|
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: | Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| Start Your 30-Day Free Trial |
| Upgrade Your Subscription | Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. | Upgrade Now |
|
| Manage Your Watchlist | View and add up to five holdings to your watchlist. | View My Portfolio |
|
| Join Our Facebook Group | Join MarketBeat's free stock discussion and trading idea group on Facebook. | Join Now |
|
|
No comments:
Post a Comment